口腔菌群与胰腺癌的相关性研究进展

[1]	Gopinath D, Menon RK, Banerjee M, et al. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: a systematic review[J]. Crit Rev Oncol Hematol, 2019, 139:31-40. doi: S1040-8428(18)30324-X pmid: 31112880
[2]	Ozkan B, Topuk SN, Taser N, et al. Oral microbiota change, tooth decay and hemorrhoidal disease[J]. Anae-robe, 2015, 33:137.
[3]	Corrêa JD, Calderaro DC, Ferreira GA, et al. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status[J]. Microbiome, 2017, 5(1):34. doi: 10.1186/s40168-017-0252-z pmid: 28320468
[4]	Corrêa JD, Fernandes GR, Calderaro DC, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients[J]. Sci Rep, 2019, 9(1):8379. doi: 10.1038/s41598-019-44674-6 pmid: 31182740
[5]	Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma[J]. Clin Microbiol Infect, 2009, 15(11):971-976.
[6]	Wang C, Li J. Pathogenic microorganisms and pancreatic cancer[J]. Gastrointest Tumors, 2015, 2(1):41-47.
[7]	Gullo L, Pezzilli R, Morselli-Labate AM, et al. Diabetes and the risk of pancreatic cancer[J]. N Engl J Med, 1994, 331(2):81-84.
[8]	Huang BZ, Pandol SJ, Jeon CY, et al. New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population[J]. Clin Gastroenterol Hepatol, 2020, 18(8):1812-1821.e7.
[9]	Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer[J]. Cancer J, 2014, 20(3):203-206.
[10]	Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer′s disease[J]. Oral Microbiol Immunol, 2002, 17(2):113-118.
[11]	Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitis-cancer association[J]. Ann Epidemiol, 2003, 13(5):312-316.
[12]	Ahn J, Segers S, Hayes RB. Periodontal disease, porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality[J]. Carcinogenesis, 2012, 33(5):1055-1058.
[13]	Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals[J]. J Natl Cancer Inst, 2007, 99(2):171-175.
[14]	Olsen I, Taubman MA, Singhrao SK. Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer′s disease[J]. J Oral Microbiol, 2016, 8:33029.
[15]	Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a po-pulation-based nested case-control study[J]. Gut, 2018, 67(1):120-127.
[16]	Wei MY, Shi S, Liang C, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected[J]. Mol Cancer, 2019, 18(1):97.
[17]	Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study[J]. Gut, 2013, 62(12):1764-1770.
[18]	Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563,e16.
[19]	Ji Y, Liang X, Lu H. Analysis of by high-throughput sequencing: helicobacter pylori infection and salivary microbiome[J]. BMC Oral Health, 2020, 20(1):84.
[20]	Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis[J]. PLoS One, 2013, 8(9):e75559.
[21]	Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer[J]. Gut, 2012, 61(4):582-588. doi: 10.1136/gutjnl-2011-300784 pmid: 21994333
[22]	Gaiser RA, Halimi A, Alkharaan H, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer[J]. Gut, 2019, 68(12):2186-2194.

口腔菌群与胰腺癌的相关性研究进展

Study on oral microflora related to pancreatic cancer

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱颖, 汤玉茗, 黄佳, 章永平, 姚玮艳. 全反式维A酸可促进肿瘤相关诱导配体对多种胰腺癌细胞的凋亡作用[J]. 内科理论与实践, 2023, 18(03): 171-176.
[2]	段中华, 王宇华, 郭斯敏. 牙周病在非酒精性脂肪性肝病中的作用及机制研究进展[J]. 内科理论与实践, 2023, 18(02): 107-110.
[3]	杨蕊馨, 杜宇童, 燕然林, 朱正纲, 李琛, 于颖彦. 消化道肿瘤单细胞转录组测序研究中生物样本前处理改良的探索[J]. 诊断学理论与实践, 2022, 21(05): 567-574.
[4]	刘庆华, 李真, 张晓伟, 张新焕, 张红. 胃镜下病理改变与血清幽门螺杆菌抗体分型的关系分析[J]. 内科理论与实践, 2022, 17(04): 313-316.
[5]	阮玉凤, 胡丽萍, 陈史蓉, 尹君, 孙璟. 上海浦东新区全科医师对规范化诊治幽门螺杆菌感染掌握程度的调研[J]. 诊断学理论与实践, 2022, 21(03): 399-404.
[6]	何敏, 刘颖斌. 可切除胰腺癌的判断标准与治疗及其争议[J]. 外科理论与实践, 2022, 27(01): 6-10.
[7]	吴莉莉, 许耀麟, 楼文晖. 放射治疗在胰腺癌治疗中的应用现状和展望[J]. 外科理论与实践, 2022, 27(01): 25-29.
[8]	王冲, 程石. 可切除胰腺癌术前减黄的共识与争议[J]. 外科理论与实践, 2022, 27(01): 30-33.
[9]	卫积书, 黄诗朦. 胰腺癌嗜神经侵袭与神经重塑的研究历史和治疗现状[J]. 外科理论与实践, 2022, 27(01): 42-45.
[10]	李晓丽, 李为光, 钱爱华, 曹国良. 胰腺癌血清微RNA-486-3p的异常表达及对细胞增殖、凋亡的影响[J]. 内科理论与实践, 2021, 16(02): 121-125.
[11]	陈莉, 王计, 彭华军, 吴小微. 胃黄色瘤的胃镜表现及临床病理特征[J]. 内科理论与实践, 2021, 16(02): 126-128.
[12]	丁方谜, 刘振东. 叉头盒蛋白D1激活细胞外信号调节激酶通路促进胰腺癌侵袭转移[J]. 外科理论与实践, 2020, 25(06): 486-492.
[13]	钱梨寒, 沈柏用. 局部进展期胰腺癌综合治疗的研究进展[J]. 外科理论与实践, 2020, 25(05): 442-446.
[14]	吴璟奕, 李国静, 费健. 以急性胰腺炎为首发表现的胰腺癌（附17例报告）[J]. 外科理论与实践, 2020, 25(04): 326-330.
[15]	孙文韬, 邓侠兴. 胰腺癌与乙型肝炎感染的研究进展[J]. 外科理论与实践, 2020, 25(02): 171-173.